Meldonix

$162.00

Availability: Out of Stock

ACTIVE HALF-LIFE 24 hours
TABLET COUNT: 50 COUNTS
 CLASSIFICATION Fatty Acid Oxidation Inhibitor
 DOSAGE 250-1000 mg/day
 ACNE No
 WATER RETENTION No
 HBR Possible
 HEPATOTOXICITY No
 AROMATIZATION No

Out of stock

SKU: EURO29798 Categories: , , ,

Description

What is Meldonium?

Meldonium is used clinically to treat angina and myocardial infarction. The first clinical trial testing the efficacy of using a combination of meldonium and lisinopril, an angiotensin-converting enzyme inhibitor, to treat chronic heart failure, was reported in 2005, and concluded that the combination of meldonium and lisinopril may improve the quality of life, exercise capacity, and mechanisms of peripheral circulation of patients with chronic heart failure.

Uses

Treat Chronic Heart Failure and Cerebral Strokes
Abstinence Syndrome
Improves Oxygen Delivery to Cells
Protects Cells from Intoxication
Excellent for Sportsmen to Improve Stamina
Improves Energy Levels and Faster Physical Recovery
What should my health care professional know before I take this medicine?

Contraindications

Hypersensitivity to meldonium or any components of the drug. Increased intracranial pressure (in case of impaired venous drainage, intracranialtumours). Pregnancy and breast-feeding periods. Children’s age.

Patients with chronic liver and renal diseases should take care in case of long-term application of the drug. Due to possible development of stimulating effect it is recommended to take the drug before noon.

How should I take this medicine?

Applied internally.
• Intellectual and physical stress (including in athletes). Adults – 1 g per day divided into two 500mg doses. Course of treatment is 10-14 days. If necessary, the treatment is repeated in 2-3 weeks.
• Athletes should take 500 mg – 1 g twice a day before training. Duration of treatment during preparatory period is 2-3 weeks, during the period of
competition – 10-14 days.
• Cardiovascular disease. As part of combined therapy: 500 mg -1 g (2-4 tablets) per day, taking the whole dose at one time or dividing for 2 takings. Course of treatment is 4-6 weeks.
• Cardialgia against the background of dyshormonal myocardiodystrophy – 500 mg per day. Course of treatment is 12 days.
• Disturbed cerebral circulation. In course of treatment after elimination of acute disorders: 500 mg – 1 g per day, taking the whole dose at one time or dividing it for 2 takings. In case of chronic disorders: 500 mg per day. General course of treatment is 4-6 weeks. Recurrent courses (usually 2-3 times a year) may be taken after consulting a doctor.
• Diseases of peripheral arteries. 500 mg twice a day.
• Abstinence syndrome in case of chronic alcoholism. 500 mg 4 times a day. Course of treatment is 7-10 days.
• Maximum daily dose is 2000 mg.

Interaction with other drugs and other types of interaction

The drug may be combined with antianginal agents, anticoagulants and antiaggregants, antiarrhythmic drugs, diuretics, and bronchial spasmolytics. It intensifies the action of coronary vasodilating drugs, some hypotensive agents, and cardiac glycosides. Taking into consideration the possible development of mild tachycardia and arterial hypotension, care should be taken when combining the drug with nitroglycerin, nifediphine, alpha-adrenoceptor blockers, hypotensive agents and peripheral vasodilators.

Application during pregnancy and breast-feeding periods

Safety of Mildronate application during the pregnancy period has not been proved. In order to avoid possible negative effect of the drug on foetus, it should not be applied during pregnancy. It is unknown whether the drug penetrates into breast milk. If mother requires treatment with Mildronate, breast-feeding shall be stopped.

Storage:

Keep away from direct sunlight.
Keep locked and away from children.
Store in dry place at room temperature.
Do not exceed storage temperature higher than 25 C

What side effects may I notice when taking this medicine?

Rarely – allergic reactions (redness, rash, itching, oedema), as well as dyspepsia, tachycardia, excitement, changes of arterial pressure.

Reviews

There are no reviews yet.

Be the first to review “Meldonix”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsMeldonix removeStanzone - Stanozolol 10mg. removeAnavamed 10mg – Oxandrolone – Deus Medical removeCytomed 25mcg – Liothyronine Sodium – Deus Medical removeDianamed 10mg – Methandienone – Deus Medical removeLetrozole 2.5mg – Anti-estrogen, decreases fat build-up and decreases water retention remove
Image
EU
EU
EU
EU
EU
EU
SKUEURO29798RF-AlphaZone-upline7147101AAS-DM-0-113101AAS-DM-0-118101AAS-DM-0-117101AAS-HB-0-139
Rating
Price$162.00$89.99 $50.00 $39.00 $40.00 $75.00
Stock

Out of stock

Out of stock

AvailabilityOut of stockOut of stock
Add to cart

Read more

Read more

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionACTIVE HALF-LIFE 24 hours TABLET COUNT: 50 COUNTS  CLASSIFICATION Fatty Acid Oxidation Inhibitor  DOSAGE 250-1000 mg/day  ACNE No  WATER RETENTION No  HBR Possible  HEPATOTOXICITY No  AROMATIZATION NoActive Ingredient: Stanozolol 10mg Tablet Count: 100 tabs Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 20-50 Mg/day Acne: Yes Water Retention: No Hbr: perhaps Hepatoxicity: yes Aromatization: No Ship From: USAActive Ingredient: Oxandrolone 10mg Active Half-life: 9 Hours Classification: Anabolic Steroid Dosage Men: 50-100 Mg/day Dosage Women: 5-30 Mg/day Acne: Rarely Water Retention: No Hbr: No Hepatoxity: Low Aromatization: NoActive Ingredient: T3 25mcg Tablet Count: 50 Counts Active Half-life: 9 Hours Classification: Peptides Dosage Men: 50-100 Mcg/day Dosage Women: 50-100 Mcg/day Acne: Rarely Water Retention: No Hbr: No Hepatology: Low Aromatization: No
Active Ingredient: Methandienone 10mg Count: 100 Tabs Active Half-life: 5-6 Hours Classification: Anabolic Steroid Acne: Yes Concentration: 10 mg/cap Presentation: 100 Capsules (Total box 1000mg) Dosage: 20-80mg per day over the course of 6-8 weeks
CTIVE INGREDIENT: Letrozole 2.5mg TABLET COUNT: 30 COUNTS ACTIVE HALF-LIFE: 9 HOURS CLASSIFICATION: ANABOLIC STEROID DOSAGE: 2.5-5 MG/DAY ACNE: RARELY WATER RETENTION: NO HBR: NO HEPATOXITY: LOW AROMATIZATION: NO Ship From: Europe
ContentWhat is Meldonium? Meldonium is used clinically to treat angina and myocardial infarction. The first clinical trial testing the efficacy of using a combination of meldonium and lisinopril, an angiotensin-converting enzyme inhibitor, to treat chronic heart failure, was reported in 2005, and concluded that the combination of meldonium and lisinopril may improve the quality of life, exercise capacity, and mechanisms of peripheral circulation of patients with chronic heart failure. Uses Treat Chronic Heart Failure and Cerebral Strokes Abstinence Syndrome Improves Oxygen Delivery to Cells Protects Cells from Intoxication Excellent for Sportsmen to Improve Stamina Improves Energy Levels and Faster Physical Recovery What should my health care professional know before I take this medicine? Contraindications Hypersensitivity to meldonium or any components of the drug. Increased intracranial pressure (in case of impaired venous drainage, intracranialtumours). Pregnancy and breast-feeding periods. Children’s age. Patients with chronic liver and renal diseases should take care in case of long-term application of the drug. Due to possible development of stimulating effect it is recommended to take the drug before noon. How should I take this medicine? Applied internally. • Intellectual and physical stress (including in athletes). Adults – 1 g per day divided into two 500mg doses. Course of treatment is 10-14 days. If necessary, the treatment is repeated in 2-3 weeks. • Athletes should take 500 mg – 1 g twice a day before training. Duration of treatment during preparatory period is 2-3 weeks, during the period of competition – 10-14 days. • Cardiovascular disease. As part of combined therapy: 500 mg -1 g (2-4 tablets) per day, taking the whole dose at one time or dividing for 2 takings. Course of treatment is 4-6 weeks. • Cardialgia against the background of dyshormonal myocardiodystrophy – 500 mg per day. Course of treatment is 12 days. • Disturbed cerebral circulation. In course of treatment after elimination of acute disorders: 500 mg – 1 g per day, taking the whole dose at one time or dividing it for 2 takings. In case of chronic disorders: 500 mg per day. General course of treatment is 4-6 weeks. Recurrent courses (usually 2-3 times a year) may be taken after consulting a doctor. • Diseases of peripheral arteries. 500 mg twice a day. • Abstinence syndrome in case of chronic alcoholism. 500 mg 4 times a day. Course of treatment is 7-10 days. • Maximum daily dose is 2000 mg. Interaction with other drugs and other types of interaction The drug may be combined with antianginal agents, anticoagulants and antiaggregants, antiarrhythmic drugs, diuretics, and bronchial spasmolytics. It intensifies the action of coronary vasodilating drugs, some hypotensive agents, and cardiac glycosides. Taking into consideration the possible development of mild tachycardia and arterial hypotension, care should be taken when combining the drug with nitroglycerin, nifediphine, alpha-adrenoceptor blockers, hypotensive agents and peripheral vasodilators. Application during pregnancy and breast-feeding periods Safety of Mildronate application during the pregnancy period has not been proved. In order to avoid possible negative effect of the drug on foetus, it should not be applied during pregnancy. It is unknown whether the drug penetrates into breast milk. If mother requires treatment with Mildronate, breast-feeding shall be stopped. Storage: Keep away from direct sunlight. Keep locked and away from children. Store in dry place at room temperature. Do not exceed storage temperature higher than 25 C What side effects may I notice when taking this medicine? Rarely – allergic reactions (redness, rash, itching, oedema), as well as dyspepsia, tachycardia, excitement, changes of arterial pressure.Stanozolol 10mg x 100 tablets Stanzolol is a derivative of dihydrotestosterone, although its activity is much milder than this androgen in nature. It is technically classified as an anabolic steroid, shown to exhibit a slightly greater tendency for muscle growth than androgenic activity in early studies.Letrozole is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozole are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozole has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of letrozole is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozole has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozole is used to treat adolescents and children with short stature.
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information